Can targeting α-synuclein slow the course of Parkinson’s disease? Despite years of trying, success has eluded scientists thus far. At the AD/PD conference, held March 17-21 in Copenhagen, Denmark, ...
In early symptomatic Alzheimer’s disease, amyloid immunotherapy confers but a slight cognitive benefit. Some scientists speculate that one reason could be the presence of other pathologies in the ...
Clinicians have started using blood tests of p-tau217, a marker of amyloid plaques, to help diagnose AD in routine patient care, not just research studies. Alas, at AD/PD 2026, held March 17-21 in ...
Yes, you read that correctly, scientists are giving acetylcholine receptor drugs another whirl in Alzheimer’s. At the AD/PD conference, held March 17–21 in Copenhagen, Denmark, Manfred Windisch of NSC ...
The MAPT haplotypes H1 and H2 are defined by a large inversion polymorphism on chromosome 17. The HI haplotype has been consistently linked to risk for several neurodegenerative diseases, particularly ...
It has been suggested that differences in mouse and human tau may partially underlie the difficulty in modeling Alzheimer’s disease in mice (see Alzforum webinar). In this knock-in model, the entire ...
This widely used tauopathy model was developed at the University of Pennsylvania School of Medicine by Virginia Lee, John Trojanowski, and colleagues. As first reported in 2007 on a mixed background, ...
In a plenary at AD/PD, Bart De Strooper offered a vision of successive cellular struggles in Alzheimer’s pathophysiology, with key moments for therapeutic intervention.
Focused ultrasound with microbubbles is a noninvasive procedure that transiently opens the blood-brain barrier (BBB) using low-intensity sound waves. The openings reseal within 24 hours. Using MRI to ...
We have developed this special section of the Alzforum website to provide a resource for all who share an intense interest in familial early onset AD (eFAD). We have created this series of articles ...
This transgenic (Tg) mouse overexpresses a mutant form of Lrrk2 (G2019S) using a bacterial artificial chromosome (BAC) (Li et al., 2010). Transgene expression is driven by the mouse Lrrk2 promoter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results